Does elevated total bilirubin with normal ALT, AST, and alkaline phosphatase suggest bilirubin-processing strain?

Elevated total bilirubin with normal ALT, AST, and alkaline phosphatase is a recognized isolated-hyperbilirubinemia pattern. In a 52-year-old man, it supports altered bilirubin handling as an initial diagnostic direction, but fractionation determines whether this inference is appropriate.

Clinical interpretation

• Normal aminotransferases argue against a current overt hepatocellular-injury pattern, which is ordinarily marked by disproportionate ALT/AST elevation.
• Normal alkaline phosphatase argues against established overt cholestasis or biliary obstruction, where ALP is usually disproportionately elevated.
• Therefore, bilirubin uptake, processing, or conjugation—particularly if bilirubin is predominantly indirect—is a more likely initial explanation than active liver-cell injury or clear cholestasis. This remains a probabilistic, not exclusionary, interpretation.

Mechanistic and diagnostic implications

• Bilirubin should be fractionated into direct (conjugated) and indirect (unconjugated) fractions as the first step.
• Indirect-predominant hyperbilirubinemia can reflect bilirubin overproduction (especially hemolysis), impaired hepatic uptake, or impaired conjugation. If hemolysis is absent and other liver tests remain normal, mild intermittent unconjugated elevation can fit Gilbert syndrome; fasting, illness, dehydration, and exertion may accentuate it.
• Hemolysis evaluation includes CBC, reticulocyte count, LDH, haptoglobin, and peripheral smear. Medication review is relevant because rifampin, probenecid, and atazanavir can alter bilirubin uptake or conjugation.
• Direct-predominant bilirubin changes the interpretation: it can indicate hepatocellular disease, cholestasis/biliary obstruction, drug effects, or inherited excretory disorders, often prompting urinalysis and right-upper-quadrant ultrasound.

Bottom line

• The stated pattern supports bilirubin-processing/conjugation impairment over overt hepatocellular injury or cholestasis, especially with indirect-predominant bilirubin, but it does not rule out hepatic or biliary disease; bilirubin fractionation and targeted follow-up determine the cause.